SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Adeshwar Meditex informs about disclosure

23 Aug 2023 Evaluate
In terms of Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015, Adeshwar Meditex has informed that it enclosed disclosures received from Sitanshi Parikh, being relative of promoter i.e. immediate relative to Promoter, in Form 'C' pursuant to Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding transfer of 28,11,898 equity shares held in her name (being nominee to the shares of and executor to the last Will and Testament Late Siddharth Talati) to Sucheta Talati, being the legal and beneficial owner of the said shares as per the last Will and Testament of Late Siddharth Talati.

The above information is a part of company’s filings submitted to BSE. 

Adeshwar Meditex Share Price

18.41 0.00 (0.00%)
27-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.55
Dr. Reddys Lab 1277.80
Cipla 1400.70
Zydus Lifesciences 1088.90
Lupin 2268.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×